📈 Pediatric Fluid Resuscitation Weight-Based Bolus Simulator

Estimating Weight Fast — Length-Based Tapes and Age-Based Formulas

In a crashing child, nobody has time to walk a scale into the resuscitation bay before the first dose of fluid or medication is needed. Weight-based dosing depends on a weight, so emergency medicine has built rapid estimation tools that trade a small amount of precision for enormous gains in speed: length-based tapes read off a color zone in seconds, and age-based formulas can be calculated in the clinician's head while the IV is being placed.

• 46–143 cm: Broselow tape range (length-based color zones)
• (age+4)×2: APLS formula (kg, ages 1–10 years)
• ±10–20%: Typical estimate error (vs. actual measured weight)
• <15 sec: Time to estimate (tape read or formula recall)

Why an estimate, and which tool to reach for

A measured weight is always preferred once it can be obtained without delaying care — it is the gold standard and should replace any estimate as soon as it is available. But in the opening minutes of a resuscitation, three tools dominate:

Length-based tape (Broselow-style): • The child is laid alongside a color-coded tape; the tape reads out an estimated weight and a corresponding color zone • Color zones pre-print weight-based drug doses and equipment sizes, removing a calculation step entirely • Most accurate for children within typical proportions for their length; less reliable in children who are notably over- or underweight for length, since the tape assumes a population-average build

Age-based formulas (used when no tape is at hand): • APLS/classic formula: weight (kg) ≈ (age in years + 4) × 2, reasonably reliable for ages roughly 1–10 years • Updated formulas (e.g., a 2× age + 8, or region-specific variants) have been proposed because population weights have shifted since older formulas were derived — local guidelines should specify which formula is preferred • Infants under 12 months: separate age-in-months based estimates are used, since the (age+4)×2 formula does not hold for infancy

Parental report or "best guess": • A caregiver's stated weight, when available, is often more accurate than any formula and should be used preferentially if it can be obtained in seconds • A clinician's visual "best guess" estimate, while imprecise, has been shown in some studies to perform comparably to formula-based estimates

All estimation methods are placeholders. The moment an actual scale weight is available, it supersedes the estimate for all subsequent dosing calculations — including the very fluid boluses already underway.

The Standard Weight-Based Crystalloid Bolus — 20 mL/kg, Calculated at the Bedside

Once a weight is in hand — measured or estimated — the bolus volume is a single multiplication away: weight in kilograms times a standard per-kilogram dose. For isotonic crystalloid resuscitation in shock, 20 mL/kg of normal saline or lactated Ringer's is the classic starting bolus, though more conservative dosing (10 mL/kg) is increasingly favored in specific contexts where overload risk is higher.

• 20 mL/kg: Standard bolus dose (isotonic crystalloid (NS/LR))
• 10 mL/kg: Conservative alternative (cardiac disease, DKA, malnutrition)
• 5–20 min: Typical infusion time (via pump or pressure bag)
• 400 mL: Example: 20 kg child (one standard bolus)

Calculating and delivering the bolus

Calculation: Bolus volume (mL) = weight (kg) × dose (mL/kg) • A 12 kg toddler at 20 mL/kg → 240 mL • A 35 kg child at 20 mL/kg → 700 mL • The same arithmetic scales linearly across the pediatric weight range, which is precisely why per-kilogram dosing — not fixed adult volumes — is used in children

Fluid choice: • Isotonic crystalloids (0.9% normal saline or balanced solutions such as lactated Ringer's) are first-line — they stay largely intravascular in the short term and do not require cross-matching • Hypotonic fluids are avoided for resuscitation boluses; they redistribute into cells and worsen cerebral edema risk • Colloid (e.g., albumin) is reserved for specific situations, not routine first-line bolusing

Dose selection — 20 mL/kg vs. more conservative dosing: • 20 mL/kg has been the traditional teaching for hypovolemic and septic shock resuscitation • More conservative initial dosing (10 mL/kg) is increasingly favored for children with suspected cardiac disease, diabetic ketoacidosis, severe malnutrition, or in settings where large trials (e.g., the FEAST trial in febrile children in resource-limited settings) raised concern that liberal bolusing can worsen outcomes in some populations • The dose is a starting point, not a mandate to complete regardless of the child in front of you — the underlying clinical context always modifies the default

Delivery mechanics: • Delivered rapidly — typically over 5 to 20 minutes — via a pressure bag, rapid infuser, or push-pull syringe technique in smaller children, not a routine gravity drip • IV or intraosseous access is equally acceptable when peripheral access is difficult or delayed • The bolus is a discrete, timed event, not a rate — this matters for the next stage, where each bolus becomes one data point in a reassessment cycle.

Bolus, Then Reassess — Titrating Fluid to Physiologic Response, Not to a Fixed Total

The most important discipline in pediatric fluid resuscitation is not the arithmetic — it is the loop. Give the bolus over its defined short window, then stop and actually look at the child: perfusion, mental status, heart rate, blood pressure, work of breathing. Only that reassessment — not a pre-set total volume — determines whether another bolus is given.

• HR · cap refill · MS · BP: Reassessment checkpoints (after every single bolus)
• ~10–15 min: Typical cycle length (infuse, then reassess)
• ~40–60 mL/kg: Escalation trigger (cumulative volume without response)
• Bolus again? Or escalate?: Decision at each checkpoint (never automatic)

What "reassess" actually means between boluses

After each bolus finishes infusing, a structured reassessment — not a glance — determines the next step:

Perfusion: • Capillary refill time (ideally <2 seconds centrally) • Peripheral pulse quality and symmetry versus central pulses • Skin temperature and mottling, extremity warmth

Mental status: • Improving alertness and interactiveness is one of the most reassuring signs of restored perfusion • A child who was lethargic and is now tracking, crying, and resisting the exam is responding

Vital signs: • Heart rate trending toward age-appropriate range (tachycardia improving, not worsening) • Blood pressure — remembering that hypotension is a late and ominous sign in children, who compensate with tachycardia and vasoconstriction long before pressure drops • Urine output, when a catheter is in place, as a slower but valuable perfusion marker

Respiratory status: • Work of breathing, oxygen saturation, and new crackles are checked at every cycle — because this is where early overload first declares itself (see Stage 4)

The decision point: • Improved and stable → hold further boluses, transition to maintenance fluids, continue monitoring • Ongoing signs of shock, no overload signs → repeat another weight-based bolus and reassess again • Ongoing shock but overload signs emerging → the calculus shifts toward vasoactive support rather than another bolus (Stage 4–5) • This is fundamentally different from a "give X total mL and move on" protocol — the volume of fluid a given child ultimately needs is discovered through the cycle, not decided in advance.

When Rescue Fluid Becomes Harm — Recognizing Overload After Repeated Boluses

Every bolus given also has a cost. Children — especially infants and younger children with less cardiac reserve and smaller intravascular-to-extravascular buffering capacity — can tip from under-resuscitated to fluid-overloaded within just a few boluses. Hepatomegaly, new rales, and worsening respiratory status are the clinical signs that force a reassessment of the whole strategy, not just the next dose.

• Hepatomegaly: Most sensitive early sign (palpable liver edge, infants especially)
• New/worsening rales: Pulmonary sign (crackles on auscultation)
• ~2–3 boluses: Risk inflection point (cumulative ~40–60 mL/kg)
• FEAST trial: Evidence of harm (liberal bolusing, higher mortality subset)

Signs to actively look for, and why the risk is not uniform

Clinical signs of evolving fluid overload:

• Hepatomegaly — often the earliest and most sensitive sign in infants and young children, reflecting hepatic venous congestion before pulmonary edema is clinically obvious; the liver edge should be checked at every reassessment, not just once • New or worsening rales/crackles on lung auscultation • Increasing work of breathing — tachypnea, retractions, grunting — that was not present, or was less pronounced, before the most recent bolus • Gallop rhythm (S3) on cardiac auscultation • Periorbital or peripheral edema, though these develop more slowly and are less useful acutely • Declining oxygen saturation without another clear explanation

Why risk rises specifically after repeated boluses: • Each subsequent bolus adds to a cumulative volume that a child's cardiovascular and renal systems must handle; the first bolus is rarely the problem, but the second or third can tip a child with limited cardiac reserve into congestion • Children with underlying cardiac disease, severe anemia, malnutrition, or very young age have less physiologic buffer and develop overload signs earlier and with less volume • Evidence from large studies — most notably the FEAST trial in febrile children with impaired perfusion in a resource-limited setting — found that liberal fluid bolusing was associated with increased mortality in a specific patient population, which reshaped global thinking about reflexive, unlimited bolusing

What changes clinically once overload signs appear: • The default of "still in shock → give another bolus" no longer applies unmodified • The clinician now weighs ongoing hypoperfusion against the measured harm already appearing — this is exactly the judgment call that separates protocol-following from clinical reasoning • Overload signs plus persistent shock is one of the clearest triggers to move toward the next stage: vasoactive support rather than more volume.

Beyond the Bolus — Vasoactive Support and Reassessing the Underlying Cause

Fluid-refractory shock — persistent hypoperfusion despite a reasonable course of weight-based boluses — is not a signal to keep bolusing indefinitely. It is a signal to change strategy: start vasoactive medication to support perfusion pharmacologically, and step back to ask whether the presumed diagnosis is actually correct.

• ~40–60 mL/kg: "Fluid-refractory" threshold (without adequate response)
• Epinephrine / norepinephrine: First-line vasoactive agents (per current pediatric shock guidance)
• Cardiogenic · obstructive · hemorrhagic: Reconsider etiology (not all shock is fluid-responsive)
• Central or reliable IO/IV: Access needed (for vasoactive infusion)

Why the strategy changes, and what changes with it

Recognizing fluid-refractory shock: • A child who remains tachycardic, poorly perfused, or mentally obtunded after roughly 40–60 mL/kg of crystalloid — given as sequential, reassessed boluses rather than one indiscriminate infusion — has not simply received "not enough fluid yet" • Continuing to chase perfusion with volume alone, especially once overload signs are present (Stage 4), trades one form of harm for another

Starting vasoactive support: • Epinephrine or norepinephrine infusions are favored as first-line vasoactive agents in current pediatric septic shock guidance, titrated to a target blood pressure and perfusion endpoint • Vasoactive infusions require reliable access — a central line is preferred for prolonged use, though peripheral or intraosseous infusions can bridge the gap while central access is obtained • Starting a vasoactive agent does not mean fluid is abandoned entirely — maintenance fluids continue, and further small boluses may still be considered — but volume is no longer the primary lever being pulled

Reassessing the underlying cause: • Persistent shock despite fluid and vasoactive support should always prompt a return to first principles: is this actually hypovolemic/septic shock, or is it cardiogenic (myocarditis, congenital heart disease), obstructive (tension pneumothorax, cardiac tamponade), or hemorrhagic shock requiring blood products and source control rather than more crystalloid? • Point-of-care ultrasound, repeat physical exam focused on cardiac and pulmonary findings, and laboratory data (lactate trend, hemoglobin, blood gas) all help distinguish these categories at this decision point • The clinical lesson across the whole simulator: fluid boluses are a rapid, powerful, but explicitly time- and volume-limited first response — not an unlimited resource to lean on when a child is not improving.

The overarching principle across all five stages is titration, not a fixed recipe: estimate weight quickly when needed, calculate the standard per-kilogram bolus, give it over a defined short window, reassess before repeating, watch for overload from the very first repeat bolus onward, and be ready to pivot to vasoactive support and a fresh diagnostic look once fluid alone stops working.